I. Caramazza

发表

Intraduodenal absorption of the new UF-heparin salt ITF 1057 in the conscious dog.

A. Crema, F. De Ponti, G. D'atri, 1991, Thrombosis research.

Structural requirements for duodenal permeability of heparin-diamine complexes.

T. Ohno, G. Zoppetti, Y. Murakami, 1992, Biochimica et biophysica acta.

Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activity.

L. Lopalco, A. Siccardi, F. Leoni, 1994, AIDS research and human retroviruses.

Dietary iron deficiency in the rat. II. Recovery from energy metabolism derangement of the hepatic tissue by iron therapy.

D. Ceccarelli, T. Trenti, A. Masini, 1994, Biochimica et biophysica acta.

Chemical and biological characterization of iron-protein succinylate (ITF 282).

P. Cremonesi, I. Caramazza, 1993, International journal of clinical pharmacology, therapy and toxicology.

Effects of iron compounds on the gastroenteric tract: Comparison of ferrous sulfate with iron-succinyl-albumin (ITF 1096)

A. Crema, P. Cremonesi, I. Caramazza, 1990 .

Gastrointestinal effects of single and repeated doses of ferrous sulphate in rats.

L. Cuzzolin, M. Donini, P. del Soldato, 1993, Pharmacological research.

Comparison of anti-anaemic effects of iron protein succinylate (ITF 282) and ferrous sulfate in the rat.

I. Scagnol, P. del Soldato, I. Caramazza, 1990, Drugs under experimental and clinical research.

Intraduodenal absorption in the rabbit of a novel heparin salt.

P. del Soldato, G. Zoppetti, A. Sala, 1992, Haemostasis.

Heparin by alternative routes of administration.

G Andriuoli, M Bossi, I Caramazza, 1990, Haemostasis.